Prostanoids and cancer.
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D002471:Cell Transformation, Neoplastic / Q000187:drug effects; D004537:Eicosanoic Acids / Q000096:biosynthesis; D005227:Fatty Acids / Q000378:metabolism*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy / Q000378:metabolism*; D011448:Prostaglandin Antagonists / Q000627:therapeutic use; D011453:Prostaglandins / Q000097:blood / Q000494:pharmacology; D011466:Prostanoic Acids / Q000378:metabolism*
D000893:Anti-Inflammatory Agents; D004537:Eicosanoic Acids; D005227:Fatty Acids; D011448:Prostaglandin Antagonists; D011453:Prostaglandins; D011466:Prostanoic Acids